Home » Stocks » CPHI

China Pharma Holdings, Inc. (CPHI)

Stock Price: $0.707 USD -0.013 (-1.85%)
Updated Jun 11, 2021 4:00 PM EDT - Market closed
Market Cap 30.80M
Revenue (ttm) 11.46M
Net Income (ttm) -2.97M
Shares Out 43.58M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 11
Last Price $0.707
Previous Close $0.720
Change ($) -0.013
Change (%) -1.85%
Day's Open 0.750
Day's Range 0.700 - 0.750
Day's Volume 518,085
52-Week Range 0.320 - 1.630

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

HAIKOU, China, June 9, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced plans to launch...

4 days ago - PRNewsWire

HAIKOU, China, May 14, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced financial resul...

4 weeks ago - PRNewsWire

HAIKOU, China, April 19, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, commented on the policy state...

1 month ago - PRNewsWire

Shares of several penny stocks are on the rise today as Reddit investors continue to pick out the top ones to take a risk on. The post Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, C...

Other stocks mentioned: CYAN, SEAC, UPC, BAYP
2 months ago - InvestorPlace

HAIKOU CITY, China , March 26, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI)  ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrate...

2 months ago - PRNewsWire

Face mask play China Pharma Holdings is trending higher today, and investors are noticing. Here is what you should know about CPHI stock.

7 months ago - InvestorPlace

China Pharma Holdings Inc. (CPHI) CEO Zhilin Li on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

China Pharma's (CPHI) CEO Zhilin Li on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q4 2018 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

About CPHI

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of th... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
CEO
Zhilin Li
Employees
237
Stock Exchange
NYSEAMERICAN
Ticker Symbol
CPHI
Full Company Profile

Financial Performance

In 2020, CPHI's revenue was $10.87 million, a decrease of -0.53% compared to the previous year's $10.92 million. Losses were -$2.87 million, -86.15% less than in 2019.

Financial Statements